Treatment of postmenopausal osteoporosis with calcitriol or calcium.

[1]  J. Gallagher,et al.  Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. , 1990, Annals of internal medicine.

[2]  M. Tilyard.  Low-dose calcitriol versus calcium in established postmenopausal osteoporosis. , 1990, Metabolism: clinical and experimental.

[3]  H. DeLuca.  Osteoporosis and the metabolites of vitamin D. , 1990, Metabolism: clinical and experimental.

[4]  W M O'Fallon,et al.  Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. , 1990, The New England journal of medicine.

[5]  B. Riggs,et al.  The Effect of Calcitriol on Patients with Postmenopausal Osteoporosis with Special Reference to Fracture Frequency , 1989, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[6]  S. Ott,et al.  Calcitriol treatment is not effective in postmenopausal osteoporosis. , 1989, Annals of internal medicine.

[7]  J. Aloia,et al.  Calcitriol in the treatment of postmenopausal osteoporosis. , 1988, The American journal of medicine.

[8]  B. Riggs,et al.  Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis. , 1985, The Journal of clinical endocrinology and metabolism.

[9]  J. Aloia,et al.  Risk factors for postmenopausal osteoporosis. , 1985, The American journal of medicine.

[10]  M. Horowitz,et al.  1,25-Dihydroxycalciferol and calcium therapy in osteoporosis with calcium malabsorption. Dose response relationship of calcium absorption and indices of bone turnover. , 1985, Mineral and electrolyte metabolism.

[11]  C. Christiansen,et al.  Effect of 1,25-dihydroxyvitamin D3 on biochemical indices of bone turnover in postmenopausal women. , 2009, Acta medica Scandinavica.

[12]  R. Nuti,et al.  The hormonal form of vitamin D in the pathophysiology and therapy of postmenopausal osteoporosis , 1984, Journal of endocrinological investigation.

[13]  R. Nuti,et al.  Vitamin D metabolites in postmenopausal osteoporosis. , 1984, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[14]  J. Zerwekh,et al.  Long term 25-hydroxyvitamin D3 therapy in postmenopausal osteoporosis: demonstration of responsive and nonresponsive subgroups. , 1983, The Journal of clinical endocrinology and metabolism.

[15]  L. Mosekilde,et al.  Acute effects of parathyroid hormone on vitamin D metabolism in patients with the bone loss of aging. , 1982, The Journal of clinical endocrinology and metabolism.

[16]  C. Christiansen,et al.  TREATMENT OF POST MENOPAUSAL OSTEOPOROSIS. A CONTROLLED THERAPEUTIC TRIAL COMPARING OESTROGEN/GESTAGEN, 1,25‐DIHYDROXY‐VITAMIN D3 AND CALCIUM , 1982, Clinical endocrinology.

[17]  E. Agner,et al.  Serum 1,25-Dihydroxyvitamin D in Normal Subjects and in Patients with Postmenopausal Osteopenia. Influence of Age, Renal Function and Oestrogen Therapy , 1982, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[18]  H. DeLuca,et al.  Assessment of 25-hydroxyvitamin D 1 alpha-hydroxylase reserve in postmenopausal osteoporosis by administration of parathyroid extract. , 1981, The Journal of clinical endocrinology and metabolism.

[19]  J. Adams,et al.  Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. , 1981, The New England journal of medicine.

[20]  M. Peacock,et al.  The vitamin D metabolites in the pathogenesis and management of osteoporosis. , 1981, Current medical research and opinion.

[21]  H. DeLuca,et al.  Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. , 1980, The Journal of clinical endocrinology and metabolism.

[22]  J. Zerwekh,et al.  Ability of 25-hydroxyvitamin D3 therapy to augment serum 1,25- and 24,25-dihydroxyvitamin D in postmenopausal osteoporosis. , 1980, The Journal of clinical endocrinology and metabolism.

[23]  H. DeLuca,et al.  Serum 1,25-dihydroxyvitamin D levels in normal children and in vitamin D disorders. , 1980, American journal of diseases of children.

[24]  H. DeLuca,et al.  Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. , 1979, The Journal of clinical investigation.

[25]  H. DeLuca.  Recent advances in our understanding of the vitamin D endocrine system. , 1979, Journal of steroid biochemistry.

[26]  R. Kumar,et al.  Elevated 1,25-dihydroxyvitamin D plasma levels in normal human pregnancy and lactation. , 1979, The Journal of clinical investigation.

[27]  H. DeLuca,et al.  A syndrome of osteoporosis, increased serum immunoreactive parathyroid hormone, and inappropriately low serum 1,25-dihydroxyvitamin D. , 1978, Mayo Clinic proceedings.